Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05650086 · ClinicalTrials.gov registry record
Novel Thermal Imaging Technique for Breast Screening
A clinical trial, sponsored by University of Arizona.
- Terminated
- Registry status
- 115
- Enrollment target
NCT05650086 is a clinical trial that was terminated before completion, run by University of Arizona. The registered enrollment target is 115 participants.
The verdict
NCT05650086 was terminated before completion, sponsored by University of Arizona.
- TERMINATED
- Registry status
- 115 participants
- Enrollment target
Study Summary
This trial is to study a new breast imaging tool called Thermalytix™. ThermalytixTM is a new radiation-free, automated breast cancer screening technique that uses Artificial Intelligence (AI) over thermal images. Thermal images are heat signatures in our body. This new technique will capture heat signatures in the breast and analyze those images with AI software. This study will evaluate the performance of ThermalytixTM breast imaging against standard imaging modalities, such as mammography and ultrasound.
Interventions
- DEVICE Thermalytix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2022-11-15 |
| Est. Completion | 2023-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05650086
The ClinicalTrials.gov registry entry for NCT05650086 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Thermalytix is the first listed.
NCT05650086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05650086 about?
NCT05650086 is a clinical study titled "Novel Thermal Imaging Technique for Breast Screening". This trial is to study a new breast imaging tool called Thermalytix™. ThermalytixTM is a new radiation-free, automated breast cancer screening technique that uses Artificial Intelligence (AI) over thermal images. Thermal images are heat signatures in our body. This new technique will capture heat si...
What is the current status of trial NCT05650086?
This trial is currently terminated. The enrollment target is 115 participants. The study started on 2022-11-15. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT05650086?
The interventions under investigation include: Thermalytix (DEVICE).
Who is sponsoring clinical trial NCT05650086?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.